RecruitingPhase 2NCT06561321
Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar Keratoderma
Studying Hereditary palmoplantar keratoderma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Indiana University
- Principal Investigator
- David Rosmarin, MDDermatology
- Intervention
- Tapinarof(drug)
- Enrollment
- 6 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2027
Study locations (1)
- Indiana University Department of Dermatology, Indianapolis, Indiana, United States
Collaborators
Organon and Co
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06561321 on ClinicalTrials.gov